| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 244,601 | 156,545 |
| Effect of foreign exchange rate changes | 567 | 1,247 |
| Net increase in cash, cash equivalents and restricted cash | 42,046 | 16,360 |
| Cash and cash equivalents at beginning of period | 122,053 | - |
| Cash and cash equivalents at end of period | 164,099 | - |
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)